Investing Profile

DanDan Dong

InvestorVC
Vivo Capital - Managing Director
Photo of DanDan Dong, Managing Director at Vivo Capital
cb
Vivo Capital Managing Director
$10.0M - $50.0M
$25.0M
3
$1.4B
CompanyStageDateRound SizeTotal Raised
Visen Pharmaceuticals
Series BJan 2021$150M
Series ANov 2018$40M
$190M
Kira Pharmaceuticals
Series BJan 2021$54M
$100M
Co-investors: Nisa Leung (Qiming Venture Partners)